TL;DR: Blue Cross Blue Shield of Illinois (BCBSIL) helped hundreds of employers strip out coverage for gender-affirming care, even though the insurance company itself treats that care as medically necessary in other plans. They offered standard exclusion wording, asked no questions about medical need or motive, and processed denials for puberty blockers and surgery for transgender adolescents and adults.
Families appealed and lost. One plaintiff (person filing the lawsuit) paid out of pocket for surgery after a refused claim that was supposedly to be covered.
A federal court recently described how BCBSIL receives federal health dollars, promises to follow anti-discrimination rules, and still enforces these illegal exclusions for self-funded employers.
This story shows how corporate incentives and a deregulated benefits system leave transgender workers and their children to carry the risk.
Keep reading for how this setup works, who pays the price, and what it reveals about neoliberal capitalism and corporate social responsibility.
Table of Contents
- A System Built to Deny
- How BCBSIL Enforced Discriminatory Exclusions
- Timeline of Key Events
- Regulatory Loopholes and Deregulation in Health Benefits
- Profit-Maximization at All Costs
- Economic Fallout for Transgender Patients and Families
- Public Health Impact of Denied Gender-Affirming Care
- Workers and Families Trapped in Employer Health Plans
- Wealth Disparity, Corporate Ethics, and Neoliberal Capitalism
- Legal Minimalism and Compliance as Branding
- Capitalism and Delay: The Strategic Value of a Long Lawsuit
- Corporate Accountability and the Limits of the Courts
A System Built to Deny
The court record describes a health-care giant that split its business in two. In one part of its operation, Blue Cross Blue Shield of Illinois sells fully insured plans and covers gender-affirming care, which it treats as medically necessary treatment for adolescents with gender dysphoria.
In another part of its operation, the same company serves as a third-party administrator for self-funded employer plans and allows those employers to carve out that same care entirely.
BCBSIL tells self-funded employers they can “add or remove any benefits that they wish.” Hundreds of employers took that offer.
Three hundred ninety-eight sponsors chose to exclude gender-affirming care.
The company provided “standard language” for these exclusions, and 378 of those 398 employers used that language. BCBSIL never asks employers for a medical, scientific, or religious justification. The record states that the company would administer the exclusion even if the employer wanted it for discriminatory purposes.
For families of transgender children and adults, those choices turned into concrete harm.
Puberty-blocking implants were first approved and then reversed as “erroneous.” Appeals were denied. Coverage for chest surgery recommended by treating physicians was rejected. One transgender man paid out of pocket for gender-affirming surgery and then had his reimbursement claim denied.
At the same time, BCBSIL receives federal funds for several health products, including Medicare and Medicaid-related coverage, and promises to comply with federal non-discrimination rules.
The appellate court (appeals court) held that these federal dollars place the company’s health insurance operations under Section 1557 of the Affordable Care Act, which bars sex-based discrimination in any health program where any part receives federal financial assistance. I’ll go into more detail about that later in some easier to understand language, so don’t worry ^.^
This case shows how a large insurer can shape benefits design, absorb federal money, and still enforce sweeping exclusions that fall on one of the most vulnerable groups in the health system: transgender patients and their families.
How BCBSIL Enforced Discriminatory Exclusions
The class action centers on BCBSIL’s role as a third-party administrator for self-funded, employer-sponsored health plans. Employers in this model assume the financial risk for claims and hire a company like BCBSIL to assemble provider networks, process claims, and implement the plan’s terms.
In that role, BCBSIL:
- Allowed employers to remove coverage for gender-affirming care entirely.
- Offered a standard exclusion clause targeted at gender-affirming care, which hundreds of employers adopted.
- Used diagnosis and procedure codes to identify whether claims fell into those exclusions and then denied them.
- Sent Explanation of Benefits notices to members that reflected those denials.
The class includes people in self-funded ERISA plans administered by BCBSIL with categorical exclusions for some or all gender-affirming health care services, where the person’s treatment was denied solely because of that exclusion during a class period beginning November 23, 2016.
Human Impact in the Record
- C.P., a young transgender man, was diagnosed with gender dysphoria and covered by a BCBSIL-administered plan sponsored by Catholic Health Initiatives. That plan excluded treatment, drugs, therapy, and supplies “for, or leading to, gender reassignment surgery.” C.P.’s doctor prescribed a puberty-delaying implant. BCBSIL first covered it, then reversed that coverage as an error based on the exclusion, denied the family’s appeal, and then denied coverage for a second implant. The company also denied coverage for chest surgery that C.P.’s doctor recommended as gender-affirming treatment. A BCBSIL representative described that surgery as necessary, yet the exclusion still controlled the result.
- S.L., a transgender girl with gender dysphoria and precocious puberty, was enrolled in a self-funded plan BCBSIL administered. Her provider prescribed puberty-delaying hormones. BCBSIL denied coverage, citing an exclusion on “gender reassignment surgery” and related services and supplies. Her mother appealed, and the appeal was denied.
- Emmett Jones, a transgender man with gender dysphoria, was enrolled in the same plan as C.P. His providers recommended gender-affirming chest surgery. He paid for the surgery out of pocket and sought reimbursement. BCBSIL denied his claim based on the exclusion.
These families faced systemic refusal of care that their doctors considered necessary for their health. The insurer’s internal view of the care as medically necessary in its own insured products did not protect them in the self-funded segment.
Timeline of Key Events
All dates below come directly from the court record.
| Date | Event | Impact on Patients and Class |
|---|---|---|
| Nov 23, 2016 | Start of class period | Denials of gender-affirming care under BCBSIL-administered self-funded plans during this period fall within the class definition. |
| Nov 23, 2020 | C.P. and Patricia Pritchard file suit against BCBSIL | Families begin federal litigation to challenge BCBSIL’s enforcement of gender-affirming care exclusions. |
| Sept 10, 2021 | Motion to file amended class complaint | Case expands from an individual dispute to a proposed class action on behalf of similarly situated people. |
| Nov 9, 2022 | District court certifies the class (later amended in Dec 2022 and Dec 2023) | Thousands of current, former, and future plan participants enter the case as a certified class. |
| Dec 19, 2022 | District court grants summary judgment to Plaintiffs, denies BCBSIL’s motion | Court holds BCBSIL liable under Section 1557 for enforcing exclusions on gender-affirming care. |
| Post-Dec 2022 | District court orders BCBSIL to stop enforcing exclusions and re-process claims; BCBSIL appeals; injunction stayed | Court orders structural relief, yet those reforms pause while the appeal proceeds. |
| Jan 15, 2025 | Case argued in the Ninth Circuit in Pasadena, California | Appellate review begins on BCBSIL’s liability and the scope of Section 1557. |
| Nov 17, 2025 | Ninth Circuit vacates summary judgment and remands in light of a new Supreme Court decision (United States v. Skrmetti) | Families lose a clear win and face renewed uncertainty, even though key defenses raised by BCBSIL are rejected. |
The appeals court affirms that BCBSIL is subject to Section 1557 and can be liable as a third-party administrator, and that RFRA does not shield the company here. It sends the case back only on the remaining question of whether these exclusions count as sex-based discrimination after a new Supreme Court decision.
Regulatory Loopholes and Deregulation in Health Benefits
The opinion describes the architecture that makes this kind of harm possible. Most people with private coverage get it through employer-sponsored group plans. Employers can either buy a fully insured product or run a self-funded plan and hire an outside company to administer it. The latter model is backed by federal law governing employee benefits.
Under that framework:
- Employers enjoy wide leeway to design welfare plans, including which treatments to exclude.
- Third-party administrators like BCBSIL process claims “in accordance with the documents and instruments governing the plan.”
- The Employee Retirement Income Security Act (ERISA) includes language that seems, at first glance, to tie administrators to the plan terms.
The appellate court explains that ERISA does not compel an administrator to enforce unlawful terms. Fiduciary duties do not require a company to violate other federal statutes.
The opinion quotes ERISA’s own rule that nothing in the benefits law “shall be construed to alter, amend, modify, invalidate, impair, or supersede any law of the United States.”
This record shows a familiar pattern under neoliberal capitalism.
Regulators and lawmakers design systems that give private employers and financial intermediaries extensive freedom over benefits.
Enforcement of civil-rights protections depends on later litigation and complex statutory interpretation. Large companies then argue that they are just “following the plan,” even though they are the ones deciding how aggressively to administer exclusions that predictably harm marginalized groups.
Profit-Maximization at All Costs
The opinion does not list profit figures or internal financial goals. It does show the alignment of incentives.
BCBSIL receives federal funds for several health insurance products, agrees to comply with Section 1557’s non-discrimination rules, and still offers self-funded clients the ability to strip out coverage for gender-affirming care. The company:
- Lets employers “add or remove any benefits that they wish.”
- Supplies boilerplate exclusion language that employers use almost uniformly.
- Does not require any medical, scientific, or religious rationale.
- States that it would administer an exclusion even when an employer adopts it for discriminatory reasons.
These actions treat gender-affirming care as a negotiable line item in corporate health plans.
The record describes a standard practice for handling these claims.
BCBSIL staff look at the diagnostic code and the service code, classify the care as gender reassignment-related under the exclusion, and deny the claim. That process adjusts the company’s workload and preserves relationships with cost-conscious or ideologically motivated employers, while shifting the medical and financial burden onto transgender patients and their families.
Under neoliberal capitalism, corporate social responsibility often arrives only when it aligns with revenue, growth, or brand protection. In this case, the court record shows BCBSIL willing to implement an exclusion that targets a stigmatized group, without inquiry into justification, even while it publicly participates in federally funded programs that impose equality requirements.
Economic Fallout for Transgender Patients and Families
The legal filings that I’m pulling this story from gives only snapshots of the financial impact, which are enough to show a pattern of economic harm.
- When BCBSIL reversed coverage for C.P.’s puberty-delaying implant and denied a second one, his family lost critical insurance support for treatment prescribed by his doctor.
- When BCBSIL denied coverage for C.P.’s chest surgery and for Emmett Jones’s gender-affirming chest surgery, the cost shifted to the patients. Jones paid out of pocket and then had his reimbursement claim denied.
In employer-based insurance, a denial like this can equal months or years of wages for a working-class family. The court’s description of a class covering all such denials from late 2016 onward points toward repeated, systemic economic damage, even when the record does not list every bill or collection notice.
Under late-stage capitalism, health insurers and employers reduce expenses by targeting care that is expensive, stigmatized, or politically contentious. The costs do not vanish.
They move to the people least able to absorb them: transgender teens and adults who need treatment to function at school, at work, and in daily life, and their caregivers who already depend on employer paychecks and health benefits.
Public Health Impact of Denied Gender-Affirming Care
The opinion sets out basic medical facts. Gender identity is a person’s inner sense of being male, female, or another gender. Most people are cisgender, and their gender identity matches the sex they were assigned at birth based on external genitalia. Transgender people experience a mismatch between their gender identity and their assigned sex.
The American Psychiatric Association recognizes that gender incongruence by itself is not a mental disorder. Gender dysphoria arises when the incongruence causes serious distress or impairment in major areas of life. Untreated gender dysphoria can lead to anxiety, depression, suicide, and other mental health problems.
Clinicians treat gender dysphoria using:
- Counseling.
- Hormone therapy that reduces hormones associated with the person’s birth sex and increases hormones associated with their actual gender.
- Surgeries such as chest reconstruction, hysterectomy, or phalloplasty for transgender men, and vaginoplasty, breast reduction, or orchiectomy for transgender women.
- Puberty-delaying medication for some adolescents, which prevents development of characteristics linked to the sex assigned at birth!
The opinion notes that BCBSIL considers gender-affirming treatments medically necessary for adolescents with gender dysphoria in its fully insured plans. The same company denies coverage for closely related treatment in self-funded plans when an exclusion applies.
That split undermines public health. It creates a two-tier system where a teenager’s access to medically acknowledged care depends on the technical funding arrangement behind their insurance card. Neoliberal health policy often funnels life-and-death decisions through contract terms rather than population-level health goals. This case shows how that structure invites corporations to treat public-health risk as a secondary concern.
Workers and Families Trapped in Employer Health Plans
The record explains that most people get coverage from their employer or a family member’s employer. That employer chooses whether to fully insure or self-fund and chooses the scope of covered services. Families like those of C.P., S.L., and Emmett Jones rely on this coverage for routine care and emergencies.
When a massive company like BCBSIL tells employers they can remove any benefit they wish, workers and dependents receive a plan that reflects corporate budgets and ideological preferences. The court record shows:
- A religiously affiliated sponsor, Catholic Health Initiatives, requested an exclusion for gender-affirming care for religious reasons.
- BCBSIL is itself a secular corporation and still enforced that exclusion by denying care to a transgender adolescent and an adult under that plan.
Under neoliberal capitalism, workers are tied to employers for both wages and essential health coverage. Benefits become tools of corporate control and cost management. The result in this case is clear: trans workers and their children bear the risk of exclusions that serve employer ideology and insurer convenience.
Wealth Disparity, Corporate Ethics, and Neoliberal Capitalism
The facts in the legal opinion (attached down below) illustrates a broader pattern. One plan holder was able to pay for surgery up front and then seek reimbursement. Many transgender people in similar plans lack that option given how expensive gender affirming care can be. We’re talking 5 digits price tags here.
Corporate benefit design in a deregulatory neoliberal system favors those with savings, credit, or family support. Exclusions for gender-affirming care widen existing wealth gaps:
- People with assets can sometimes bridge the denial and pay anyway, while carrying debt or draining savings.
- People living paycheck to paycheck may cancel or postpone care entirely.
BCBSIL’s willingness to enforce categorical exclusions that target a vulnerable group, even as it acknowledges the medical necessity of that care in other lines of business, raises profound corporate ethics questions. Corporate social responsibility messaging often highlights inclusion and diversity.
The legal record here exposes how internal ethics yield to the structure of contracts and revenue when regulators and courts give room for that choice.
Legal Minimalism and Compliance as Branding
The appellate opinion describes BCBSIL’s legal defenses in detail. The company argued:
- That Section 1557 did not apply to it for these self-funded plans because those plans themselves did not receive federal funds.
- That ERISA required it to follow plan documents, including exclusions, and that this shielded the company when it implemented employer-chosen terms.
- That the Religious Freedom Restoration Act (RFRA) protected it because some employer sponsors had religious objections to gender-affirming care.
The court rejects those defenses. It holds that:
- Section 1557 applies to the company because its health insurance operations constitute a “health program or activity” and some part receives federal financial assistance.
- ERISA does not give administrators a license to break other federal laws.
- RFRA does not provide a defense here. BCBSIL is a secular entity, its own religious exercise is not burdened, and RFRA’s structure focuses on government defendants, not private lawsuits like this one.
This pattern matches a common feature of neoliberal capitalism: legal minimalism. Large institutions design compliance programs around the narrowest possible reading of their obligations and treat equality requirements as risks to be negotiated rather than moral baselines. The record shows BCBSIL attempting to escape accountability by slicing its operations into funded and unfunded segments and by leaning on the form of plan documents, even as federal civil-rights law treats the entity’s health program as a whole.
Compliance becomes a technical exercise and a public-relations shield. The substance of who gets care and who gets denied becomes secondary.
Capitalism and Delay: The Strategic Value of a Long Lawsuit
The timeline in this case spans a class period starting in 2016, a complaint filed in 2020, class certification and summary judgment in 2022, and an appellate decision in late 2025. During this time, exclusions remained in place. The district court ultimately ordered BCBSIL to stop enforcing gender-affirming care exclusions and to re-process claims, and then stayed that relief while the appeal moved forward.
This progression shows how time functions under late-stage capitalism. A corporation can continue a contested practice for years while courts interpret new Supreme Court rulings and parse statutory language. Every month of litigation is another month of denied care and unpaid claims for transgender patients and families.
The court notes that BCBSIL now faces a “dilemma” under ERISA and Section 1557: risk liability to plan participants if it enforces discriminatory terms, or risk liability to plan sponsors if it refuses to enforce those terms. The company assumed this risk when it accepted fiduciary duties and chose to administer plans with exclusions that target a vulnerable group!
Capitalism often rewards those who can sustain delay. Large corporations can fund years of litigation and absorb legal costs as a business expense. Individuals who need puberty blockers or surgery cannot delay puberty or disease progression in the same way. The mismatch in who benefits from time is part of the system.
Corporate Accountability and the Limits of the Courts
The appellate court rejects three of Blue Cross Blue Shield’s four core defenses. It holds that:
- BCBSIL’s health insurance operations are subject to Section 1557 because the company receives federal financial assistance for some products.
- Third-party administrators can be liable under Section 1557 when they implement discriminatory plan terms.
- RFRA does not shield BCBSIL here.
The appellate panel vacates (sends back for more discussing) the district court’s summary judgment for the plaintiffs (victims) and for reconsideration in light of a recent different supreme court decision. It points out that:
- Some plaintiffs had diagnoses other than gender dysphoria that would normally entitle them to hormones or other treatment, yet BCBSIL still refused coverage because of the exclusion.
- The record may support an argument that BCBSIL’s justifications are a pretext for invidious discrimination
💡 Explore Corporate Misconduct by Category
Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.
- 💀 Product Safety Violations — When companies risk lives for profit.
- 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
- 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
- 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
- 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.
